Restricted accessEditorialFirst published online 2006-10
Indication for Carotid Endarterectomy versus Carotid Stenting for the Prevention of Brain Embolization from Carotid Artery Plaques: In Search of Consensus
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351: 1379–1387.
2.
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273: 1421–1428.
3.
FergusonGGEliasziwMBarrHW. The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients. Stroke. 1999; 30: 1751–1758.
4.
HallidayAMansfieldAMarroJ. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet. 2004; 363: 1491–1502.
5.
MooreWSBarnettHJBeebeHG. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation. 1995; 91: 566–579.
6.
GorelickPBSaccoRLSmithDB. Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999; 281: 1112–1120.
7.
BarnettHJEliasziwMMeldrumHE. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients?Neurology. 1996; 46: 603–608.
8.
BarnettHJ. The inappropriate use of carotid endarterectomy. CMAJ. 2004; 171: 473–474.
9.
BarnettHJMeldrumHEEliasziwM. The dilemma of surgical treatment for patients with asymptomatic carotid disease. Ann Intern Med.1995; 123: 723–725.
10.
CebulRDSnowRJPineR. Indications, outcomes, and provider volumes for carotid endarterectomy. JAMA. 1998; 279: 1282–1287.
11.
KarpHRFlandersWDShippCC. Carotid endarterectomy among Medicare beneficiaries: A statewide evaluation of appropriateness and outcome. Stroke. 1998; 29: 46–52.
ChaturvediSAggarwalRMurugappanA. Results of carotid endarterectomy with prospective neurologist follow-up. Neurology. 2000; 55: 769–772.
14.
SegalHERummelLWuB. The utility of PRO data on surgical volume: The example of carotid endarterectomy. QRB Qual Rev Bull.1993; 19: 152–157.
15.
KantonenILepantaloMSaleniusJP. Influence of surgical experience on the results of carotid surgery. The Finnvasc Study Group. Eur J Vasc Endovasc Surg.1998; 15: 155–160.
MathiesenEBBonaaKHJoakimsenO. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: The Tromso study. Circulation. 2001; 103: 2171–2175.
18.
PolakJFShemanskiLO'LearyDH. Hypoechoic plaque at US of the carotid artery: An independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology. 1998; 208: 649–654.
19.
NicolaidesANKakkosSKGriffinM. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: Results from the asymptomatic carotid stenosis and risk of stroke study. Vascular. 2005; 13: 211–221.
20.
RothwellPM. ACST: Which subgroups will benefit most from carotid endarterectomy?Lancet. 2004; 364: 1122–1123.
21.
MasuhrFBuschM. ACST: Which subgroups will benefit most from carotid endarterectomy?Lancet. 2004; 364: 1123–1124.
22.
KietselaerBLHofstraLNarulaJ. ACST: Which subgroups will benefit most from carotid endarterectomy?Lancet. 2004; 364: 1124–1125.
23.
FinstererJStollbergerC. ACST: Which subgroups will benefit most from carotid endarterectomy?Lancet. 2004; 364: 1124.
24.
KumarSSinhaB. ACST: Which subgroups will benefit most from carotid endarterectomy?Lancet. 2004; 364: 1125.
WholeyMHWholeyMH. The history and current status of endovascular management for the extracranial carotid and supra-aortic vessels. J Endovasc Ther.2004; 11(suppl II): II–43–II–61.
31.
WholeyMHAl-MubarakNWholeyMH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv.2003; 60: 259–266.
32.
CARESS Steering Committee. Carotid Revascularization using Endarterectomy or Stenting Systems (CARESS): Phase I clinical trial. J Endovasc Ther.2003; 10: 1021–1030.
33.
CARESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg.2005; 42: 213–219.
34.
KastrupAGroschelKKrapfH. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: A systematic review of the literature. Stroke. 2003; 34: 813–819.
35.
BarnettHJTaylorDWEliasziwM. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med.1998; 339: 1415–1425.
36.
HobsonRWHowardVJRoubinGS. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg.2004; 40: 1106–1111.
37.
YadavJSWholeyMHKuntzRE. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med.2004; 351: 1493–1501.
38.
BrownMMHackeW. Carotid artery stenting: The need for randomised trials. Cerebrovasc Dis.2004; 18: 57–61.
39.
RinglebPKunzeAAllenbergJ. The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy trial. Cerebrovasc Dis.2004; 18: 66–68.
40.
FeatherstoneRLBrownMMCowardLJ. International carotid stenting study: Protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis.2004; 18: 69–74.
41.
HackeWBrownMMMasJL. Carotid endarterectomy versus stenting: An international perspective. Stroke. 2006; 37: 344.
42.
EVA-3S Investigators. Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Cerebrovasc Dis.2004; 18: 62–65.
43.
BillerJFeinbergWMCastaldoJE. Guidelines for carotid endarterectomy. A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1998; 97: 501–509.
44.
CowardLJFeatherstoneRLBrownMM. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: A Cochrane systematic review of the randomized evidence. Stroke. 2005; 36: 905–911.
45.
MozesGSullivanTMTorres-RussottoDR. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: Implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg.2004; 39: 958–966.
46.
NguyenLLConteMSReedAB. Carotid endarterectomy: Who is the high-risk patient?Semin Vasc Surg.2004; 17: 219–223.
47.
BallottaEDa GiauGBaracchiniC. Carotid endarterectomy in high-risk patients: A challenge for endovascular procedure protocols. Surgery. 2004; 135: 74–80.
48.
BallottaEDa GiauGMilitelloC. High-grade symptomatic and asymptomatic carotid stenosis in the very elderly. A challenge for proponents of carotid angioplasty and stenting. BMC Cardiovasc Disord. 2006; 6: 12.
49.
PulliRDorigoWBarbantiE. Does the high-risk patient for carotid endarterectomy really exist?Am J Surg.2005; 189: 714–719.
ReedABGaccionePBelkinM. Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk. J Vasc Surg.2003; 37: 1191–1199.
52.
IlligKAZhangRTanskiW. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?J Vasc Surg.2003; 37: 575–581.
53.
BoulesTNProctorMCArefA. Carotid endarterectomy remains the standard of care, even in high-risk surgical patients. Ann Surg.2005; 241: 356–363.
CollinsRArmitageJParishS. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004; 363: 757–767.
56.
AmarencoPLabreucheJLavalleeP. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke. 2004; 35: 2902–2909.
57.
O'Neil-CallahanKKatsimaglisGTepperMR. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: The Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol.2005; 45: 336–342.
58.
PoldermansDBaxJJKertaiMD. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003; 107: 1848–1851.
59.
Martin-VenturaJLBlanco-ColioLMGomez-HernandezA. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke. 2005; 36: 1796–1800.
60.
CrisbyMNordin-FredrikssonGShahPK. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation. 2001; 103: 926–933.
61.
WatanabeKSugiyamaSKugiyamaK. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol.2005; 46: 2022–2030.
62.
BiasiGMFroioADiethrichEB. Carotid plaque echolucency increases the risk of stroke in carotid stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004; 110: 756–762.
63.
HondaOSugiyamaSKugiyamaK. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol.2004; 43: 1177–1184.
64.
McGirtMJPerlerBABrookeBS. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg.2005; 42: 829–837.
65.
KennedyJQuanHBuchanAM. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005; 36: 2072–2076.
WierzbickiASPostonRFerroA. The lipid and non-lipid effects of statins. Pharmacol Ther.2003; 99: 95–112.
68.
NaylorAR. Does the modern concept of ‘best medical therapy’ render carotid surgery obsolete?Eur J Vasc Endovasc Surg.2004; 28: 457–461.
69.
BiasiGM. Is it time to reconsider the selection criteria for conventional or endovascular repair of carotid artery stenosis in the prevention of cerebral ischemia?J Endovasc Ther.2001; 8: 339–340.
70.
DiethrichEB. Characterizing the carotid revascularization candidate: Will plaque morphology be important?J Endovasc Ther.2001; 8: 44–45.
71.
BiasiGMMingazziniPMBaronioL. Carotid plaque characterization using digital image processing and its potential in future studies of carotid endarterectomy and angioplasty. J Endovasc Surg.1998; 5: 240–246.
72.
BiasiGMSampaoloAMingazziniP. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcation lesions. Eur J Vasc Endovasc Surg.1999; 17: 476–479.
73.
AbuRahmaAFCovelliMARobinsonPA. The role of carotid duplex ultrasound in evaluating plaque morphology: Potential use in selecting patients for carotid stenting. J Endovasc Surg.1999; 6: 59–65.
74.
JordanWDVoellingerDCDoblarDD. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg.1999; 7: 33–38.
OhkiTMarinMLLyonRT. Ex vivo human carotid artery bifurcation stenting: Correlation of lesion characteristics with embolic potential. J Vasc Surg.1998; 27: 463–471.
80.
BarnettHJEliasziwMMeldrumH. Plaque morphology as a risk factor for stroke. JAMA. 2000; 284: 177.
81.
BiasiGMMingazziniPMSampaoloA. Echographic characterization of the carotid plaque and risk of cerebral ischemia. Vol V: Ed Minerva Medica; 1995.
HenryMHenryIKlonarisC. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system: Midterm results. J Endovasc Ther.2002; 9: 1–13.
84.
AckerstaffRGJansenCMollFL. The significance of microemboli detection by means of transcranial Doppler ultrasonography monitoring in carotid endarterectomy. J Vasc Surg.1995; 21: 963–969.
85.
TublerTSchluterMDirschO. Balloon-protected carotid artery stenting: Relationship of periprocedural neurological complications with the size of particulate debris. Circulation. 2001; 104: 2791–2796.
86.
BiasiGMFerrariSANicolaidesAN. The ICAROS registry of carotid artery stenting. Imaging in Carotid Angioplasties and Risk of Stroke. J Endovasc Ther.2001; 8: 46–52.
87.
SetacciCde DonatoGSetacciF. In-stent restenosis after carotid angioplasty and stenting: A challenge for the vascular surgeon. Eur J Vasc Endovasc Surg.2005; 29: 601–607.
88.
JaegerHJMathiasKDHauthE. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol.2002; 23: 200–207.
SchluterMTublerTSteffensJC. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol.2003; 42: 1007–1013.
91.
WolfOHeiderPHeinzM. Microembolic signals detected by transcranial Doppler sonography during carotid endarterectomy and correlation with serial diffusion-weighted imaging. Stroke. 2004; 35: e373–375.
92.
LiebetrauMSteenBHamannGF. Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: A population-based study in 85-year-old subjects. Stroke. 2004; 35: 1816–1820.
93.
VermeerSEPrinsNDden HeijerT. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med.2003; 348: 1215–1222.
94.
MathiesenEBBonaaKHJoakimsenO. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: The Tromso study. Stroke. 2001; 32: 1960–1965.
95.
GronholdtMLNordestgaardBGNielsenTG. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke. 1996; 27: 2166–2172.
96.
YamagamiHKitagawaKNagaiY. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke. 2004; 35: 677–681.
97.
JohnsenSHMathiesenEBFosseE. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: A follow-up study of 1952 persons with carotid atherosclerosis the Tromso study. Circulation. 2005; 112: 498–504.
98.
CremonesiAManettiRLisoA. Endovascular treatment of soft carotid plaques: A single-center carotid stent experience. J Endovasc Ther.2006; 13: 190–195.
BosiersMDelooseKVerbistJ. Review of stents for the carotid artery. J Cardiovasc Surg (Torino). 2006; 47: 107–113.
101.
TanakaNMartinJBTokunagaK. Conformity of carotid stents with vascular anatomy: Evaluation in carotid models. AJNR Am J Neuroradiol.2004; 25: 604–607.
102.
BosiersMDelooseKVerbistJ. Carotid artery stenting: Which stent for which lesion?Vascular. 2005; 13: 205–210.
103.
HalmEAHannanELRojasM. Clinical and operative predictors of outcomes of carotid endarterectomy. J Vasc Surg.2005; 42: 420–428.
104.
RerkasemKBondRRothwellPM. Local versus general anaesthesia for carotid endarterectomy. Cochrane Database Syst Rev.2004(2): CD000126.
105.
BondRRerkasemKAbuRahmaAF. Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev.2004(2): CD000160.
106.
DevereauxPJBeattieWSChoiPT. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005; 331: 313–321.
107.
LindenauerPKPekowPWangK. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med.2005; 353: 349–361.